Dr. Lubitz graduated from the University of Michigan Medical School. He trained in internal medicine and cardiovascular disease at the Mount Sinai Hospital in New York, where he also served as a Chief Medical Resident. Dr. Lubitz earned a Master of Public Health degree from the Harvard University School of Public Health. He completed his clinical electrophysiology training at the Massachusetts General Hospital.
His clinical interests are focused on the diagnosis and treatment of patients with cardiac arrhythmias. He performs catheter ablations for supraventricular tachycardias (SVTs), and implantation and follow-up of pacemakers, cardiac resynchronization therapy (CRT) devices, and implantable cardioverter defibrillators (ICDs).
Dr. Lubitz has clinical and research interests in caring for patients with heritable arrhythmias, including early onset atrial fibrillation, Brugada syndrome, long QT syndrome, short QT syndrome, unexplained ventricular tachycardia and fibrillation, arrhythmogenic right ventricular cardiomyopathy, and catecholaminergic polymorphic ventricular tachycardia.
Dr. Lubitz is currently accepting new patients.
ResearchDr. Lubitz' research focuses on clinical and genetic aspects of heritable cardiac arrhythmias. He is interested in studying the mechanisms of heritable arrhythmias and determining how genetic information can be used to guide care. Dr. Lubitz' research spans disciplines including epidemiology, risk prediction, population genetics, pharmacogenetics, and clinical trials to identify the role of using genetic information in clinical practice.